Posts filed under ‘Antimicoticos’

Candida Prosthetic Joint Infection. A Review of Treatment Methods.

J Bone Jt Infect. 2017 Feb 5;2(2):114-121.

Cobo F1, Rodríguez-Granger J1, Sampedro A1, Aliaga-Martínez L2, Navarro-Marí JM1.

Author information

1 Department of Microbiology, Hospital Virgen de las Nieves, Granada, Spain.

2 Department of Internal Medicine, Hospital Virgen de las Nieves, Granada, Spain.

Abstract

Fungal microorganisms are still a rare cause of bone and joint infections. We report a new case of knee prosthetic joint infection due to Candida albicans in a patient with a previous two-stage right knee arthroplasty for septic arthritis due to S. epidermidis occurred several months ago. Moreover, the treatment in 76 cases of Candida prosthetic joint infection has been discussed. Forty patients were female and mean age at diagnosis was 65.7 (± SD 18) yrs. No risk factors for candidal infection were found in 25 patients. Infection site was the knee in 38 patients and hip in 36; pain was present in 44 patients and swelling in 24. The most frequent species was C. albicans, followed by C. parapsilosis. Eleven patients were only treated with antifungal drugs being the outcome favourable in all of them. Two-stage exchange arthroplasty was performed in 30 patients, and resection arthroplasty in other 30; in three patients one-stage exchange arthroplasty was done. A favourable outcome was found in 58 patients after antifungal plus surgical treatment, in 11 after antifungal treatment alone and in one after surgery alone. The type of treatment is still not clearly defined and an algorithm for treatment in fungal PJI should be established, but various types of surgical procedures may be applied.

PDF

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441142/pdf/jbjiv02p0114.pdf

June 20, 2017 at 2:24 pm

EDITOR’S CHOICE – Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is Associated With Improved Outcomes in Neonates

Clin Inf Dis May 15, 2017 V.64 N.10

David A. Kaufman; Sarah A. Coggins; Santina A. Zanelli; Jörn-Hendrik Weitkamp

Congenital cutaneous candidiasis is an invasive infection that presents as a diffuse manifold rash in preterm and term infants. Prompt systemic antifungal treatment at the time of skin presentation for ≥14 days prevents dissemination and Candida-related mortality.

PDF

https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/64/10/10.1093_cid_cix119/2/cix119.pdf?Expires=1494188981&Signature=As7CZ4o~tlrnN2zkl0UkHRQrAKKIRoTO~r85rRTGKiYj1cA3H910v7JHemJMekh3KX99jp0G5V8pV~WNM3nSwiDncC6F0AGNrpnZu5mbQN7l~yelvKuYpdbyW2FA3yTx4E~4PhffmFa1LagrFALYBbrATe4ZGpsezzF5cjvn3gO~WJ32urEosvc4HokBxnhiQ~GQ9eXjNp7qcRIguE9MkcbZjovt~6tRMKgKaSDF35BpQgVX4KvkHj1-UVsmE8L1g4pg-DcDW5SLlFZZhSXSAdheUjt-IlD98J-~scPkM5YJwTguujen1xRhOoDv9d1cX-EHT~KVZvHY2cEDRNyILA__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q

 

May 6, 2017 at 3:52 pm

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris

Emerging Infectious Diseases February 2017 V.23 N.2

Dispatch

Leighann Sherry, Gordon Ramage, Ryan Kean, Andrew Borman, Elizabeth M. Johnson, Malcolm D. Richardson, and Riina Rautemaa-RichardsonComments to Author

University of Glasgow, Glasgow, Scotland, UK (L. Sherry, G. Ramage, R. Kean); Public Health England, Bristol, UK (A. Borman, E.M. Johnson); The University of Manchester, Manchester, UK (M.D. Richardson, R. Rautemaa-Richardson); University Hospital of South Manchester, Manchester (M.D. Richardson, R. Rautemaa-Richardson)

The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections.

We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidine in vitro.

PDF

https://wwwnc.cdc.gov/eid/article/23/2/pdfs/16-1320.pdf

April 10, 2017 at 3:30 pm

Estimating the burden of invasive and serious fungal disease in the United Kingdom

Journal of Infection January 2017 V.74 N.1

Matthew Pegorie a, David W. Denning b,c,d, *, William Welfare a,d

a Public Health England North West Health Protection Team (Greater Manchester), UK

bNational Aspergillosis Centre, University Hospital of South Manchester, Manchester, UK

c The University of Manchester, Manchester, UK

d Manchester Academic Health Sciences Centre, University of Manchester, UK

Background: The burden of fungal disease in the UK is unknown. Only limited data are systematically collected. We have estimated the annual burden of invasive and serious fungal disease.

Methods: We used several estimation approaches. We searched and assessed published estimates of incidence, prevalence or burden of specific conditions in various high risk groups. Studies with adequate internal and external validity allowed extrapolation to estimate current UK burden. For conditions without adequate published estimates, we sought expert advice.

Results: The UK population in 2011 was 63,182,000 with 18% aged under 15 and 16% over 65. The following annual burden estimates were calculated: invasive candidiasis 5142; Candida peritonitis complicating chronic ambulatory peritoneal dialysis 88; Pneumocystis pneumonia 207e587 cases, invasive aspergillosis (IA), excluding critical care patients 2901e2912, and IA in critical care patients 387e1345 patients, <100 cryptococcal meningitis cases. We estimated 178,000 (50,000e250,000) allergic bronchopulmonary aspergillosis cases in people with asthma, and 873 adults and 278 children with cystic fibrosis. Chronic pulmonary aspergillosis is estimated to affect 3600 patients, based on burden estimates post tuberculosis and in sarcoidosis.

Conclusions: Uncertainty is intrinsic to most burden estimates due to diagnostic limitations, lack of national surveillance systems, few published studies and methodological limitations. The largest uncertainty surrounds IA in critical care patients. Further research is needed to produce a more robust estimate of total burden

PDF

http://www.journalofinfection.com/article/S0163-4453(16)30273-0/pdf

March 25, 2017 at 5:40 pm

Maxillary Sinusitis Caused by Actinomucor elegans

JOURNAL OF CLINICAL MICROBIOLOGY Feb. 2001, p. 740–742

GRACIELA DAVEL,1 * PATRICIA FEATHERSTON,2 ANIBAL FERNA´NDEZ,2 RUBEN ABRANTES,1 CRISTINA CANTEROS,1 LAURA RODERO,1 CARLOS SZTERN,3 AND DIEGO PERROTTA1

Departamento Micologıa, INEI, ANLIS Dr. Carlos G. Malbran, Buenos Aires,1 and Hospital San Juan de Dios2 and Fundacion Jose Marıa Mainetti, Centro Oncologico,3 La Plata, Argentina

We report the first case of maxillary sinusitis caused by Actinomucor elegans in an 11-year-old patient. Histopathological and mycological examinations of surgical maxillary sinuses samples showed coenocytic hyphae characteristic of mucoraceous fungi. The fungi recovered had stolons and rhizoids, nonapophyseal and globose sporangia, and whorled branched sporangiophores and was identified as A. elegans. After surgical cleaning and chemotherapy with amphotericin B administered intravenously and by irrigation, the patient became asymptomatic and the mycological study results were negative.

PDF

http://jcm.asm.org/content/39/2/740.full.pdf

February 22, 2017 at 8:46 am

Fatal Actinomucor elegans var. kuwaitiensis Infection following Combat Trauma

JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2009, p. 3394–3399

Charla C. Tully,1 Anna M. Romanelli,2 Deanna A. Sutton,3,4 Brian L. Wickes,2,4 and Duane R. Hospenthal4,5*

Department of Medicine, Wilford Hall Medical Center, Lackland Air Force Base, Lackland,1 Department of Microbiology and Immunology2 and Fungus Testing Laboratory, Department of Pathology,3 University of Texas Health Science Center at San Antonio, San Antonio, San Antonio Center for Medical Mycology, San Antonio,4 and Infectious Disease Service, Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Houston,5 Texas

A previously healthy 30-year-old male was injured by an improvised explosive device in Iraq, sustaining extensive wounds to his right side. He was evacuated to a military hospital in Iraq and taken immediately to the operating room for complex pelvic fracture debridement and fixation, right lower extremity disarticulation, right through-the-elbow amputation, and an exploratory laparotomy. He was stabilized and evacuated to a military medical center in Germany. After further evaluation and stabilization, including washing out of his right flank, hip, and forearm and washing out of his abdomen without evidence of bowel injury, a wound vacuum-assisted closure device was placed over his open abdomen, and he was transferred to Brooke Army Medical Center (BAMC) for further care …

PDF

http://jcm.asm.org/content/47/10/3394.full.pdf

February 22, 2017 at 8:45 am

Flow Cytometry To Assess Cerebrospinal Fluid Fungal Burden in Cryptococcal Meningitis

Journal of Clinical Microbiology March 2016 V.54 N.3 P.802-804

Mycology

James E. Scriven, Lisa M. Graham, Charlotte Schutz, Thomas J. Scriba, Robert J. Wilkinson, David R. Boulware, Graeme Meintjes, David G. Lalloo, and Britta C. Urban

aLiverpool School of Tropical Medicine, Liverpool, Merseyside, United Kingdom

bWellcome Trust Liverpool Glasgow Centre for Global Health Research, Liverpool, United Kingdom

cClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

dDepartment of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

eSouth African TB Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa

fDepartment of Medicine, Imperial College, London, United Kingdom

gFrancis Crick Institute, Mill Hill Laboratory, London, United Kingdom

hDepartment of Medicine, University of Minnesota, Minnesota, USA

James E. Scriven, jscriven@liv.ac.uk

Fungal burden in the cerebrospinal fluid is an important determinant of mortality in cryptococcal meningitis, but its use in aiding clinical decision making is hampered by the time involved to perform quantitative cultures. Here, we demonstrate the potential of flow cytometry as a novel and rapid technique to address this issue.

PDF

http://jcm.asm.org/content/54/3/802.full.pdf

February 21, 2017 at 3:24 pm

Older Posts


Calendar

June 2017
M T W T F S S
« May    
 1234
567891011
12131415161718
19202122232425
2627282930  

Posts by Month

Posts by Category